RE: RNS Patent update9 Sep 2020 10:36
Mogul1...if Synairgen simply do a deal with a Pharma, then the IP remains with Synairgen, however, if a Pharma or ANother goes for a T/O or Buyout then they get all the IP which is where our real value lies. It will be down to our Scientists to draw up the scientific documentation for filing and I'm sure a suitor would want this all done prior to doing a deal...